Translation of new cancer treatments from pet dogs to humans
The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Naturally occurring cancers in pet dogs and humans share many features, including histological appearance, tumour genetics, molecular targets, biological behaviour and response to conventional therapies. Studying dogs with cancer is likely to provide a valuable perspective that is distinct from that generated by the study of human or rodent cancers alone. The value of this opportunity has been increasingly recognized in the field of cancer research for the identification of cancer-associated genes, the study of environmental risk factors, understanding tumour biology and progression, and, perhaps most importantly, the evaluation and development of novel cancer therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies conducted in recent years have demonstrated that the same tumor oncogenes and suppressor genes contribute to the development of cancer in humans and dogs [43].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [43]
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Bone marrow transplant: Angela Joyce on the care of children undergoing BMT for genetic disorders
Joyce, A. (1989) · Paediatric Nursing · doi:10.7748/paed.1.6.21.s21 · Cited by 3,384
Genome sequence, comparative analysis and haplotype structure of the domestic dog
members, B. S. P., Lindblad-Toh, K., Wade, C. M., Mikkelsen, T. S., Karlsson, E. K., Jaffe, D. B., Kamal, M., Clamp, M., Chang, J. L., Kulbokas, E. J., et al. (2005) · Nature · doi:10.1038/nature04338 · Cited by 2,568 · cited 1×
“In addition, the inclusion of dogs from different breeds in clinical trials provides a cross-sectional value that is often higher than that obtained in studies of inbred laboratory animals, by providing a background genetic diversity similar to that seen in human populations (on the basis of single nucleotide polymorp…”
BackgroundGastrointestinal stromal tumour
Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60780-6 · Cited by 1,036
Fine, H. A., Dear, K. B. G., Loeffler, J. S., Black, P. M., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2574::aid-cncr2820710823>3.0.co;2-1 · Cited by 861
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.031 · Cited by 717
Withrow & Macewen's Small Animal Clinical Oncology
Withrow, S. J., Vail, D. M., & Page, R. L. (2019) · Medical Entomology and Zoology · Cited by 637
Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7 · Cited by 561
Self-citationSpontaneously Occurring Tumors of Companion Animals as Models for Human Cancer
Vail, D. M., & Macewen, E. G. (2000) · Cancer Investigation · doi:10.3109/07357900009012210 · Cited by 528
Image guidance for precise conformal radiotherapy
Mackie, T. R., Kapatoes, J., Ruchala, K., Lu, W., Wu, C., Olivera, G., Forrest, L., Tome, W., Welsh, J., Jeraj, R., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00090-7 · Cited by 484
Why is cancer drug discovery so difficult?
Kamb, A., Wee, S., & Lengauer, C. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2155 · Cited by 339
Comparative Longevity of Pet Dogs and Humans: Implications for Gerontology Research
Patronek, G. J., Waters, D. J., & Glickman, L. T. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.3.b171 · Cited by 335
Khanna, C., Lindblad-Toh, K., Vail, D., London, C., Bergman, P., Barber, L., Breen, M., Kitchell, B., McNeil, E., Modiano, J. F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt0906-1065b · Cited by 334
Self-citationBergman, P. J., McKnight, J. A., Novosad, A., Charney, S. C., Farrelly, J., Craft, D. M., Wulderk, M., Jeffers, Y., Sadelain, M., Hohenhaus, A. E., et al. (2003) · PubMed · Cited by 330
Bergman, P. J., Camps-Palau, M. A., McKnight, J. A., Leibman, N. F., Craft, D. M., Leung, C., Liao, J., Riviere, I., Sadelain, M., Hohenhaus, A. E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.027 · Cited by 298
Canine Transitional Cell Carcinoma
Mutsaers, A. J., Widmer, W. R., & Knapp, D. W. (2003) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2003.tb02424.x · Cited by 281
London, C. A., Hannah, A. L., Zadovoskaya, R., Chien, M. B., Kollias-Baker, C., Rosenberg, M. P., Downing, S., Post, G. S., Boucher, J. F., Shenoy, N. R., et al. (2003) · PubMed · Cited by 280
Evaluation of a High-Dose Chemotherapy Protocol with No Maintenance Therapy for Dogs with Lymphoma
Chun, R., Garrett, L. D., & Vail, D. M. (2000) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2000.tb02224.x · Cited by 275
Evaluation of a 6-Month Chemotherapy Protocol with No Maintenance Therapy for Dogs with Lymphoma
Garrett, L. D., Thamm, D. H., Chun, R., Dudley, R., & Vail, D. M. (2002) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2002.tb02411.x · Cited by 269
Kiupel, M., Webster, J. D., Kaneene, J. B., Miller, R., & Yuzbasiyan-Gurkan, V. (2004) · Veterinary Pathology · doi:10.1354/vp.41-4-371 · Cited by 258
Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit
London, C. A., Galli, S. J., Yuuki, T., Hu, Z.-Q., Helfand, S. C., & Geissler, E. N. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00075-7 · Cited by 249
Comparative Aspects of Osteosarcoma: Dog Versus Man
WITHROW, S. J., POWERS, B. E., STRAW, R. C., & WILKINS, R. M. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00023 · Cited by 235
Spontaneous and genetically engineered animal models
Hansen, K., & Khanna, C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.031 · Cited by 222
Self-citationAmputation and Carboplatin for Treatment of Dogs With Osteosarcoma: 48 Cases (1991 to 1993)
Bergman, P. J., MacEwen, E. G., Kurzman, I. D., Henry, C. J., Hammer, A. S., Knapp, D. W., Hale, A., Kruth, S. A., Klein, M. K., Klausner, J., et al. (1996) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1996.tb02031.x · Cited by 219
Zemke, D., Yamini, B., & Yuzbasiyan-Gurkan, V. (2002) · Veterinary Pathology · doi:10.1354/vp.39-5-529 · Cited by 207
Comparative biology of human and canine osteosarcoma.
Mueller, F., Fuchs, B., & Kaser‐Hotz, B. (2007) · PubMed · Cited by 203
Norden-Zfoni, A., Desai, J., Manola, J., Beaudry, P., Force, J., Maki, R., Folkman, J., Bello, C., Baum, C., DePrimo, S. E., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0919 · Cited by 200
Mohammed, S. I., Bennett, P. F., Craig, B. Α., Glickman, N. W., Mutsaers, A. J., Snyder, P. W., Widmer, W. R., DeGortari, A. E., Bonney, P. L., & Knapp, D. W. (2002) · PubMed · Cited by 197
Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication
Meyer, J. S., Rao, B. R., Stevens, S. C., & White, W. L. (1977) · Cancer · doi:10.1002/1097-0142(197711)40:5<2102::aid-cncr2820400519>3.0.co;2-e · Cited by 193
Lingaas, F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg336 · Cited by 192
Modiano, J. F., Breen, M., Burnett, R. C., Parker, H. G., Inusah, S., Thomas, R., Avery, P. R., Lindblad-Toh, K., Ostrander, E. A., Cutter, G. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4613 · Cited by 186
Canine Transitional Cell Carcinoma
Mutsaers, A. J., Widmer, W. R., & Knapp, D. W. (2003) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2003)017 · Cited by 184
The role of KIT in the management of patients with gastrointestinal stromal tumors
Hornick, J. L., & Fletcher, C. D. M. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.03.001 · Cited by 177
Thamm, D. H., Kurzman, I. D., King, I., Li, Z., Sznol, M., Dubielzig, R. R., Vail, D. M., & MacEwen, E. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2510 · Cited by 174
Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J. G., Elzaouk, L., Pavlovic, J., & Moelling, K. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.35 · Cited by 154
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.
Liao, J., Gregor, P. D., Wolchok, J. D., Orlandi, F., Craft, D. M., Leung, C., Houghton, A. N., & Bergman, P. J. (2006) · PubMed · Cited by 144
Britten, C. D., Kabbinavar, F. F., Hecht, J. R., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0498-4 · Cited by 143
Bovine papillomaviral gene expression in equine sarcoid tumours
Nasir, L., & Reid, S. W. J. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00022-2 · Cited by 143
Kurzman, I. D., MacEwen, E. G., ROSENTHAL, R. C., Fox, L. E., Keller, E. T., Helfand, S. C., Vail, D. M., Dubielzig, R. R., Madewell, B. R., & Rodriguez, C. O. (1995) · PubMed · Cited by 142
Canine Oral Melanoma: Comparison of Surgery Versus Surgery Plus Corynebacterium parvum
MacEwen, E. G., Patnaik, A. K., Harvey, H., et al. (1986) · Cancer Investigation · doi:10.3109/07357908609017520 · Cited by 139
Forrest, L. J., Mackie, T. R., Ruchala, K., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.08.016 · Cited by 138
Limb-sparing treatment for osteosarcoma in dogs
LaRue, S. Μ., Withrow, S. J., Powers, B. E., Wrigley, R. H., Gillette, E. L., Schwarz, P. D., Straw, R. C., & Richter, S. L. (1989) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1989.195.12.1734 · Cited by 137
Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs
Otterson, G. A., Villalona-Calero, M. A., Sharma, S., Kris, M. G., Imondi, A. R., Gerber, M. C., White, D. A., Ratain, M. J., Schiller, J. H., Sandler, A. B., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1096 · Cited by 136
Nardin, A., Lefebvre, M., Labroquère, K., Faure, O., & Abastado, J. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056473 · Cited by 133
Vail, D. M., MacEwen, E. G., Kurzman, I. D., Dubielzig, R. R., Helfand, S. C., Kisseberth, W. C., London, C. A., Obradovich, J. E., Madewell, B. R., & Rodriguez, C. O. (1995) · PubMed · Cited by 128
DOW, S. W., Elmslie, R. E., Willson, A. P., Roche, L. M., Gorman, C., & Potter, T. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci510 · Cited by 127
Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
Pryer, N., Lee, L. B., Zadovaskaya, R., Yu, X., Sukbuntherng, J., Cherrington, J. M., & London, C. A. (2003) · PubMed · Cited by 120
Treatment of Canine Mast Cell Tumors with CCNU (Lomustine)
Rassnick, K. M., Moore, A. S., Williams, L. E., et al. (1999) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1999.tb02217.x · Cited by 119
Anderson, P. M., Markovic, S. N., Sloan, J. A., Clawson, M. L., Wylam, M. E., Arndt, C. A. S., Smithson, W. A., Burch, P. A., Gornet, M. E., & Rahman, E. (1999) · PubMed · Cited by 118
Koenig, A., Bianco, S. R., Fosmire, S. P., Wojcieszyn, J. W., & Modiano, J. F. (2002) · Veterinary Pathology · doi:10.1354/vp.39-4-458 · Cited by 117
Efficacy of Liposomal Muramyl Tripeptide (CGP 19835A) in the Treatment of Relapsed Osteosarcoma
Kleinerman, E. S., Gano, J. B., Johnston, D. A., Benjamin, R. S., & Jaffe, N. (1995) · American Journal of Clinical Oncology · doi:10.1097/00000421-199504000-00001 · Cited by 116
MacEwen, E. G., Kurzman, I. D., Vail, D. M., Dubielzig, R. R., Everlith, K. M., Madewell, B. R., Rodriguez, C. O., Phillips, B., Zwahlen, C. H., Obradovich, J. E., et al. (1999) · PubMed · Cited by 115
Thomas, R., Smith, K. C., Ostrander, E. A., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601275 · Cited by 115
Hershey, A., Kurzman, I. D., Forrest, L. J., et al. (1999) · PubMed · Cited by 113
MacDonald, V. S., Thamm, D. H., Kurzman, I. D., et al. (2005) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2005.tb02753.x · Cited by 111
The Molecular Basis of Canine Melanoma: Pathogenesis and Trends in Diagnosis and Therapy
Modiano, J. F., Ritt, M. G., & Wojcieszyn, J. W. (1999) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1999.tb02173.x · Cited by 111
London, C. A., Kisseberth, W. C., Galli, S. J., Geissler, E. N., & Helfand, S. C. (1996) · Journal of Comparative Pathology · doi:10.1016/s0021-9975(96)80074-0 · Cited by 105
Ostrander, E. A., Giger, U., & Lindblad‐Toh, K. (2006) · Medical Entomology and Zoology · Cited by 95
Canine Mast Cell Tumors Express Stem Cell Factor Receptor
Reguera, M. J., Rabanal, R. M., Puigdemont, A., et al. (2000) · American Journal of Dermatopathology · doi:10.1097/00000372-200002000-00010 · Cited by 95
Canine models of bone marrow transplantation.
Ladiges, W. C., Storb, R., & Thomas, E. D. (1990) · PubMed · Cited by 93
Leahy, M. F., Seymour, J. F., Hicks, R. J., & Turner, J. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3470 · Cited by 93
Comparative Histopathology of Grey‐Horse‐Melanoma and Human Malignant Melanoma
Seltenhammer, M. H., Heere‐Ress, E., Brandt, S., Druml, T., Jansen, B., Pehamberger, H., & NIEBAUER, G. W. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00192.x · Cited by 91
Oncology of companion animals as a model for humans. an overview of tumor histotypes.
Porrello, A., Cardelli, P., & Spugnini, E. P. (2006) · PubMed · Cited by 87
Reiser, H., Wang, J., Chong, L., Watkins, W. J., Ray, A. S., Shibata, R., Birkuš, G., Cihlář, T., Wu, S., Li, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2061 · Cited by 87
Aberrations of the p53 tumor suppressor gene in various tumors in dogs
Setoguchi, A., Sakai, T., Okuda, M., Minehata, K., Yazawa, M., Ishizaka, T., WATARI, T., Nishimura, R., Sasaki, N., Hasegawa, A., et al. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.433 · Cited by 86
Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs
Storb, R. F., Epstein, R. B., Ragde, H., et al. (1967) · Blood · doi:10.1182/blood.v30.6.805.805 · Cited by 83
Lana, S. E., Jackson, T. L., Burnett, R. C., et al. (2006) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2006.tb02864.x · Cited by 80
Rusk, A. W., McKeegan, E. M., Haviv, F., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0109 · Cited by 77
Lana, S. E., Jackson, T. L., Burnett, R. C., et al. (2006) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2006)20[329:uopcrf]2.0.co;2 · Cited by 75
Mast Cell Tumors of the Gastrointestinal Tract in 39 Dogs
Ozaki, K., Yamagami, T., Nomura, K., et al. (2002) · Veterinary Pathology · doi:10.1354/vp.39-5-557 · Cited by 73
Knapp, D. W., & Waters, D. J. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(96)20031-0 · Cited by 73
Ferret oncology: diseases, diagnostics, and therapeutics
Antinoff, N., & Hahn, K. A. (2004) · Veterinary Clinics of North America Exotic Animal Practice · doi:10.1016/j.cvex.2004.05.001 · Cited by 73
Diagnosis of Mediastinal Masses in Dogs by Flow Cytometry
Lana, S. E., Plaza, S., Hampe, K., et al. (2006) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2006.tb00716.x · Cited by 73
Ogilvie, G. K., Richardson, R. C., Curtis, C. R., et al. (1989) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1989.195.11.1584 · Cited by 71
Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial
Klein, W. R., Bras, G. E., Misdorp, W., et al. (1986) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199861 · Cited by 70
Bukowski, J. A. (1998) · Journal of Toxicology and Environmental Health · doi:10.1080/009841098158719 · Cited by 70
Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies.
Khanna, C., Hasz, D. E., Klausner, J. S., et al. (1996) · PubMed · Cited by 68
Self-citationOgilvie, G. K., Straw, R. C., Jameson, V. J., et al. (1993) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1993.202.02.304 · Cited by 61
Whelan, H. T., Schmidt, M. H., Segura, A. D., McAuliffe, T. L., Bajic, D. M., Murray, K. J., Moulder, J. E., Strother, D. R., Thomas, J. P., & Meyer, G. A. (1993) · Journal of neurosurgery · doi:10.3171/jns.1993.79.4.0562 · Cited by 58
Khanna, C., Prehn, J., Hayden, D. W., Cassaday, R. D., Caylor, J., Jacob, S. T., Bose, S., Hong, S. H., Hewitt, S. M., & Helman, L. J. (2002) · PubMed · Cited by 56
Self-citationDetermining the Significance of Persistent Lymphocytosis
Avery, A. C., & Avery, P. R. (2007) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2006.11.001 · Cited by 55
Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumorsPreprint
Thomas, R., Scott, A., Langford, C. F., Fosmire, S. P., Jubala, C. M., Lorentzen, T. D., Hitte, C., Karlsson, E. K., Kirkness, E., Ostrander, E. A., et al. (2005) · Genome Research · doi:10.1101/gr.3825705 · Cited by 53
Aerosolized Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Therapy in Metastatic Cancer
Rao, R. D., Anderson, P. M., Arndt, C. A. S., et al. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000037664.04141.d0 · Cited by 51
Diagnosis of Mediastinal Masses in Dogs by Flow Cytometry
Lana, S. E., Plaza, S., Hampe, K., et al. (2006) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2006)20[1161:dommid]2.0.co;2 · Cited by 51
Aberrant p53 Expression in Feline Vaccine-associated Sarcomas and Correlation with Prognosis
Hershey, A., Dubielzig, R. R., Padilla, M. L., et al. (2005) · Veterinary Pathology · doi:10.1354/vp.42-6-805 · Cited by 47
Biologic Therapy for Osteosarcoma Using Liposome-Encapsulated Muramyl Tripeptide
Kleinerman, E. S. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30079-0 · Cited by 47
Estimating the Neutral Rate of Nucleotide Substitution Using Introns
Hoffman, M. M., & Birney, E. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl179 · Cited by 46
Misdorp, W., & Hart, A. A. M. (1979) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.1979.tb06744.x · Cited by 46
Nebulized Interleukin 2 Liposomes: Aerosol Characteristics and Biodistribution
Khanna, C., Waldrep, J. C., Anderson, P. M., et al. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06024.x · Cited by 44
Self-citationAerosol Therapy for Malignancy Involving the Lungs
Rao, R. D., Markovic, S. N., & Anderson, P. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481895 · Cited by 44
Overexpression of the p53 gene product in canine mammary tumors
Haga, S., Nakayama, M., Tatsumi, K., et al. (2001) · Oncology Reports · doi:10.3892/or.8.6.1215 · Cited by 43
Misdorp, W., & Hart, A. A. M. (1979) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.1979.tb06743.x · Cited by 41
MacEwen, E. G., Kurzman, I. D., Helfand, S. C., Vail, D. M., London, C. A., Kisseberth, W. C., ROSENTHAL, R. C., Fox, L. E., Keller, E. T., Obradovich, J. E., et al. (1994) · Journal of drug targeting · doi:10.3109/10611869408996814 · Cited by 40
Anderson, P. M. (2006) · Future Oncology · doi:10.2217/14796694.2.3.333 · Cited by 40
Epidemiological features of canine renal neoplasms.
Hayes, H. Μ., & Fraumeni, J. F. (1977) · PubMed · Cited by 38
Waters, D. J., & Wildasin, K. (2006) · Scientific American · doi:10.1038/scientificamerican1206-94 · Cited by 38
Twenty-Four-Hour Ambulatory Electrocardiography in Normal Cats
Ware, W. A. (1999) · Journal of Veterinary Internal Medicine · Cited by 36
Khanna, C., & Vail, D. M. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481903 · Cited by 36
Self-citationvon Mehren, M. (2006) · Clinical Colorectal Cancer · doi:10.3816/ccc.2006.s.005 · Cited by 36
O’Brien, S. J., & Murphy, W. J. (2003) · Science · doi:10.1126/science.1090531 · Cited by 32
Rusk, A. W., Cozzi, E. M., Stebbins, M. E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0110 · Cited by 31
Treatment of canine malignancies by 1200 R total body irradiation and autologous marrow grafts.
WEIDEN, P. L., Storb, R., Lerner, K. G., et al. (1975) · PubMed · Cited by 28
Using the canine genome to cure cancer and other diseases
Olson, P. N. (2007) · Theriogenology · doi:10.1016/j.theriogenology.2007.04.016 · Cited by 28
Cancer researchers usher in dog days of medicine
Mack, G. S. (2005) · Nature Medicine · doi:10.1038/nm1005-1018a · Cited by 24
Prognostic and predictive markers in canine tumours: Rationale and relevance. A review
Mukaratirwa, S. (2005) · Veterinary Quarterly · doi:10.1080/01652176.2005.9695186 · Cited by 23
High-Grade Prostatic Intraepithelial Neoplasia in Dogs
Waters, D. J. (1999) · European Urology · doi:10.1159/000019878 · Cited by 23
TUMOR VACCINES FOR IMMUNOTHERAPY OF CANINE LYMPHOSARCOMA*
Benjamini, E., Theilen, G. H., TORTEN, M., Fong, S., Crow, S. E., & Henness, A. M. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb41709.x · Cited by 20
Clinical Trials Going to the Dogs: Canine Program To Study Tumor Treatment, Biology
Mack, G. S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj061 · Cited by 19
Lymphocyte reactivity to autochthonous tumor cells in dogs with spontaneous malignancies
Tsoi, M.-S., Weiden, P. L., & Storb, R. F. (1974) · Cellular Immunology · doi:10.1016/0008-8749(74)90262-7 · Cited by 13
SPATIAL ACCURACY OF FRACTIONATED IMRT DELIVERY STUDIES IN CANINE PARASPINAL IRRADIATION
Kippenes, H., Gavin, P. R., Parsaei, H., et al. (2003) · Veterinary Radiology & Ultrasound · doi:10.1111/j.1740-8261.2003.tb00469.x · Cited by 13
DOW, S. W., & Potter, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119450 · Cited by 8
Animal Modeling and Thermal Dose
Dewhirst, M. W. (1989) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)02136-4 · Cited by 8
Genetic immunotherapy for cancer
Elmslie, R. E., & DOW, S. W. (1997) · Topics in companion animal medicine · doi:10.1016/s1096-2867(97)80033-3 · Cited by 7
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma
Tomita, N., Kodama, F., Oshima, R., et al. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500472784 · Cited by 4
Legeza, V. I., Shagoyan, M. G., Mf, K., et al. (1982) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00830668 · Cited by 3
Vi, L., Mg, S., Mf, K., et al. (1982) · PubMed · Cited by 2
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
Wc, L., STORB, R., Raff, R. F., et al. (1990) · PubMed · Cited by 2
Ks, M., Grigor'ev, I. G., Mv, B., et al. (2002) · PubMed · Cited by 2
Newly approved therapies for RCC and their effect on the standard of care.
Figlin, R. A. (2007) · PubMed · Cited by 1
Research works printed but not linked: 1
- Withrow, S. J. et al. Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma. Cancer 71, 2484–2490 (1993). · doi:10.1002/1097-0142(19930415)71:8<2484::aid-cncr2820710810>3.0.co;2-d
Cited by
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Intratumoral injection of Clostridium novyi -NT spores induces antitumor responses
Roberts, N. J., Zhang, L., Janku, F., Collins, A., Bai, R.-Y., Staedtke, V., Rusk, A. W., Tung, D., Miller, M., Roix, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008982 · Cited by 400
Dog models of naturally occurring cancer
Rowell, J. L., McCarthy, D. O., & Alvarez, C. E. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.004 · Cited by 384
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Breed-Predispositions to Cancer in Pedigree Dogs
Dobson, J. M. (2013) · ISRN Veterinary Science · doi:10.1155/2013/941275 · Cited by 334
Metadata
- Authors
- Paoloni, M., & Khanna, C.
- Affiliations
- National Cancer Institute (US)
- Corresponding author
- Khanna, Chand
- Venue
- Nature Reviews Cancer
- Published
- 2008-02
- Volume
- 8
- Issue
- 2
- Pages
- 147-156
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2064349256
- Semantic Scholar
- 057a521a408ad8c8f558966caf143533ee591701
- Cited by
- 668
- References
- 119
- Citations by year
- 2026: 36 · 2025: 26 · 2024: 18 · 2023: 36 · 2022: 29 · 2021: 30 · 2020: 50 · 2019: 45 · 2018: 32 · 2017: 37 · 2016: 46 · 2015: 45 · 2014: 49 · 2013: 51 · 2012: 33
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Veterinary Oncology Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Human-Animal Interaction Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- canine cancer, canine model, translational oncology, cancer therapeutics, comparative oncology, cancer genetics, tumor biology, cancer genes, environmental risk factors, tumor progression
- MeSH terms
- Animals, Base Sequence, Clinical Trials as Topic, Disease Models, Animal, Dogs, Humans, Medical Oncology, Models, Genetic, Molecular Sequence Data, Neoplasms, Research Design, Risk Factors, Sequence Homology, Nucleic Acid, Sequence Analysis, DNA, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.